Skip to main content

TRUIST FINANCIAL CORP

Position in NBIX — Neurocrine Biosciences Inc

CIK 92230 CHARLOTTE, NC

Position in NBIX

as of Mar 31, 2026 · filed Apr 27, 2026
Position Value
$1,471,271
-$87,581 QoQ
Shares Held
11,168
+1.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 48.325573065902574.ToString("F0")% Shared 0.ToString("F0")% None 51.67442693409742.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

TRUIST FINANCIAL CORP holds $44,449,493 across 15 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (3.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 NBIX
Neurocrine Biosciences Inc
This page
11,168 $1,471,271

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,471,271 11,168
2025-12-31 $1,558,852 10,991
2025-09-30 $4,958,782 35,324
2025-06-30 $5,027,724 40,001
2025-03-31 $3,902,630 35,286
2024-12-31 $6,337,012 46,425
2024-09-30 $24,689,686 214,283
2024-06-30 $4,342,937 31,546
2024-03-31 $5,151,036 37,348
2023-12-31 $4,900,812 37,195
2023-09-30 $4,024,349 35,772
2023-06-30 $3,334,163 35,357
2023-03-31 $4,211,864 41,611
2022-12-31 $5,056,849 42,338
2022-09-30 $4,680,567 44,069
2022-06-30 $4,901,196 50,279
2022-03-31 $5,741,718 61,245
2021-12-31 $3,663,928 43,019
2021-09-30 $4,342,420 45,276
2021-06-30 $4,233,905 43,505
2021-03-31 $4,460,759 45,869
2020-12-31 $4,212,030 43,944
2020-09-30 $4,282,772 44,538
2020-06-30 $5,046,652 41,366
2020-03-31 $3,531,497 40,803